0001179110-20-005295.txt : 20200430 0001179110-20-005295.hdr.sgml : 20200430 20200430185206 ACCESSION NUMBER: 0001179110-20-005295 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200428 FILED AS OF DATE: 20200430 DATE AS OF CHANGE: 20200430 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BROSHY ERAN CENTRAL INDEX KEY: 0001256230 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36033 FILM NUMBER: 20837667 MAIL ADDRESS: STREET 1: C/O VENTIV HEALTH STREET 2: 200 COTTONTAIL LN. VANTAGE COURT N. CITY: SOMERSET STATE: NJ ZIP: 08873 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Theravance Biopharma, Inc. CENTRAL INDEX KEY: 0001583107 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 650-808-6000 MAIL ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 4 1 edgar.xml FORM 4 - X0306 4 2020-04-28 0 0001583107 Theravance Biopharma, Inc. TBPH 0001256230 BROSHY ERAN C/O THERAVANCE BIOPHARMA US, INC. 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Ordinary Shares 2020-04-28 4 A 0 6635 0 A 41206 D Share Option (Right to Buy) 30.14 2020-04-28 4 A 0 6000 0 A 2030-04-27 Ordinary Shares 6000 6000 D This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Brett A. Grimaud, Attorney-in-Fact 2020-04-30